SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 156 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $177 | +785.0% | 184 | +581.5% | 0.00% | – |
| Q1 2023 | $20 | -98.1% | 27 | -99.0% | 0.00% | – |
| Q4 2022 | $1,033 | -99.8% | 2,804 | +117.2% | 0.00% | – |
| Q3 2022 | $555,000 | -97.8% | 1,291 | -95.9% | 0.00% | – |
| Q2 2022 | $24,689,000 | +26.0% | 31,652 | +108.3% | 0.00% | – |
| Q1 2022 | $19,598,000 | -79.1% | 15,192 | -79.5% | 0.00% | – |
| Q4 2021 | $93,969,000 | -72.9% | 73,991 | -53.5% | 0.00% | – |
| Q3 2021 | $346,513,000 | +59.4% | 158,951 | +174.3% | 0.00% | – |
| Q2 2021 | $217,335,000 | -29.5% | 57,956 | -38.7% | 0.00% | – |
| Q1 2021 | $308,464,000 | -63.9% | 94,621 | -62.3% | 0.00% | -100.0% |
| Q4 2020 | $854,754,000 | +471.2% | 250,661 | +583.4% | 0.00% | – |
| Q3 2020 | $149,654,000 | +175.1% | 36,680 | +127.9% | 0.00% | – |
| Q2 2020 | $54,401,000 | -64.1% | 16,095 | -75.3% | 0.00% | – |
| Q1 2020 | $151,667,000 | +31.4% | 65,093 | +105.2% | 0.00% | – |
| Q4 2019 | $115,454,000 | -25.7% | 31,718 | +69.3% | 0.00% | – |
| Q3 2019 | $155,382,000 | +34.3% | 18,732 | +39.4% | 0.00% | – |
| Q2 2019 | $115,718,000 | -53.2% | 13,440 | -41.9% | 0.00% | -100.0% |
| Q1 2019 | $247,099,000 | +1206.8% | 23,115 | +969.6% | 0.00% | – |
| Q4 2018 | $18,909,000 | -79.7% | 2,161 | -60.9% | 0.00% | – |
| Q3 2018 | $92,938,000 | -12.7% | 5,532 | +8.9% | 0.00% | – |
| Q2 2018 | $106,435,000 | -94.6% | 5,078 | -95.9% | 0.00% | -100.0% |
| Q1 2018 | $1,989,207,000 | +188.0% | 123,630 | +239.2% | 0.00% | +300.0% |
| Q4 2017 | $690,709,000 | +22.8% | 36,449 | -8.8% | 0.00% | 0.0% |
| Q3 2017 | $562,378,000 | +253.6% | 39,970 | +87.2% | 0.00% | – |
| Q2 2017 | $159,035,000 | +114.9% | 21,347 | +87.5% | 0.00% | – |
| Q1 2017 | $74,016,000 | +30.9% | 11,387 | -10.8% | 0.00% | – |
| Q4 2016 | $56,549,000 | +7.7% | 12,765 | +13.6% | 0.00% | – |
| Q3 2016 | $52,486,000 | -58.2% | 11,239 | -41.2% | 0.00% | -100.0% |
| Q2 2016 | $125,605,000 | +129.9% | 19,118 | +122.5% | 0.00% | – |
| Q1 2016 | $54,639,000 | -40.7% | 8,591 | -43.8% | 0.00% | – |
| Q4 2015 | $92,174,000 | +9.0% | 15,286 | +8.1% | 0.00% | – |
| Q3 2015 | $84,581,000 | +121.8% | 14,144 | +153.7% | 0.00% | – |
| Q2 2015 | $38,133,000 | +307.7% | 5,575 | +261.8% | 0.00% | – |
| Q1 2015 | $9,354,000 | +133528.6% | 1,541 | +154000.0% | 0.00% | – |
| Q4 2014 | $7,000 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q3 2014 | $32,495,000 | +450.6% | 3,992 | +449.9% | 0.00% | – |
| Q2 2014 | $5,902,000 | +148.3% | 726 | +109.8% | 0.00% | – |
| Q1 2014 | $2,377,000 | -73.7% | 346 | -66.1% | 0.00% | – |
| Q4 2013 | $9,036,000 | -93.7% | 1,021 | -94.0% | 0.00% | – |
| Q3 2013 | $143,474,000 | -13.4% | 17,121 | -22.9% | 0.00% | – |
| Q2 2013 | $165,657,000 | – | 22,206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|